Global Ibuprofen Injection Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ibuprofen Injection Market Insights, Forecast to 2034
Ibuprofen injection is a nonsteroidal antiinflammatory drug (NSAID) that is used alone or together with other medicines (eg, opioid analgesics) to relieve mild to severe pain. It is also used to treat fever. This medicine is to be given only by or under the supervision of your doctor.
Global Ibuprofen Injection market is expected to reach to US$ 6010 million in 2024, with a positive growth of %, compared with US$ 5670 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Ibuprofen Injection industry is evaluated to reach US$ 9019.4 million in 2029. The CAGR will be 7.0% during 2024 to 2029.
Globally, Ibuprofen Injection key manufacturers include Cumberland Pharmaceuticals, CSL Limited, Akorn, Inc., Alveda Pharmaceuticals (Teligent), Soho Industri Pharmasi, Grifols, Easton Biopharmaceuticals, Sihuan Pharmaceutical and Chengdu Brilliant Pharmaceutical, etc. Cumberland Pharmaceuticals, CSL Limited, Akorn, Inc. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Ibuprofen Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Ibuprofen Injection market and estimated to attract more attentions from industry insiders and investors.
Ibuprofen Injection can be divided into 4ml0.4g and 8ml0.8g, etc. 4ml0.4g is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Ibuprofen Injection is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Ibuprofen Injection industry development. In 2022, global % sales of Ibuprofen Injection went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Ibuprofen Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Ibuprofen Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Cumberland Pharmaceuticals
CSL Limited
Akorn, Inc.
Alveda Pharmaceuticals (Teligent)
Soho Industri Pharmasi
Grifols
Easton Biopharmaceuticals
Sihuan Pharmaceutical
Chengdu Brilliant Pharmaceutical
Minsheng Pharmaceutical
Segment by Type
4ml0.4g
8ml0.8g
Hospitals
Clinics
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Ibuprofen Injection plant distribution, commercial date of Ibuprofen Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Ibuprofen Injection introduction, etc. Ibuprofen Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Ibuprofen Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Ibuprofen Injection market is expected to reach to US$ 6010 million in 2024, with a positive growth of %, compared with US$ 5670 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Ibuprofen Injection industry is evaluated to reach US$ 9019.4 million in 2029. The CAGR will be 7.0% during 2024 to 2029.
Globally, Ibuprofen Injection key manufacturers include Cumberland Pharmaceuticals, CSL Limited, Akorn, Inc., Alveda Pharmaceuticals (Teligent), Soho Industri Pharmasi, Grifols, Easton Biopharmaceuticals, Sihuan Pharmaceutical and Chengdu Brilliant Pharmaceutical, etc. Cumberland Pharmaceuticals, CSL Limited, Akorn, Inc. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Ibuprofen Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Ibuprofen Injection market and estimated to attract more attentions from industry insiders and investors.
Ibuprofen Injection can be divided into 4ml0.4g and 8ml0.8g, etc. 4ml0.4g is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Ibuprofen Injection is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Ibuprofen Injection industry development. In 2022, global % sales of Ibuprofen Injection went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Ibuprofen Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Ibuprofen Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Cumberland Pharmaceuticals
CSL Limited
Akorn, Inc.
Alveda Pharmaceuticals (Teligent)
Soho Industri Pharmasi
Grifols
Easton Biopharmaceuticals
Sihuan Pharmaceutical
Chengdu Brilliant Pharmaceutical
Minsheng Pharmaceutical
Segment by Type
4ml0.4g
8ml0.8g
Segment by Application
Hospitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Ibuprofen Injection plant distribution, commercial date of Ibuprofen Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Ibuprofen Injection introduction, etc. Ibuprofen Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Ibuprofen Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports